Image

So Embarrassing: Forbes Forced to Issue Correction on Their Own DOGE ‘Inaccuracies’ Article | The Gateway Pundit

In an embarrassing turn of events, Forbes has had to correct an inaccuracy in its own article about DOGE’s “inaccuracies.”

The article, titled “Here Are The Biggest DOGE Hoaxes And Inaccuracies,” penned by Conor Murray, inaccurately attempted to “debunk” that the National Institutes of Health has been funding transgender animal experiments on monkeys and mice.

Murray wrote, “While some U.S. funding has been used on research to study the effects of hormone therapy on mice—as revealed in a report from the anti-animal testing White Coat Waste Project—none involved surgery or monkeys.”

However, White Coat Waste VP Justin Goodman pointed out:

  1. This NIH grant for transgender animal experiments that we uncovered states they will surgically remove female mices’ overaies and then subject them to testosterone treatments.
  2. This NIH grant claiming to study “wound healing in transgender men, who undergo lifelong T therapy” will surgically inflict wounds on mice being exposed to testosterone.
  3. This NIH-funded study surgically implanted mice with devices to infuse them with testosterone and then cut out and dissected their bones.
  4. This NIH-funded study performed surgeries on male mice to implant devices to infuse them with estradiol gender-affirming hormone therapy
  5. In this NIH-funded study, male mice given estrogen therapy had their testicles removed.
  6. The NIH has indeed funded transgender experiments on monkeys.

The article went on to claim that the experiments were to study “hormone therapy.” However, as The Gateway Pundit recently reported, that is not true.

White Coat Waste recently exposed 15 active National Institutes of Health grants paying for transgender animal experiments, amounting to a total taxpayer cost of over $26 million.

Goodman pointed out that direct quotes from these studies include:

  • “We have developed a mouse model to mimic T treatment for FTM gender transition.”
  • “The objective of the proposed studies is to use the FTM mouse model”
  • “We will develop a mouse model of XHT (Cross-sex hormone therapy) that recapitulates clinical hormone therapy for male-to-female transition in humans.”
  • “The Alexander laboratory has developed a novel model of feminizing hormone therapy in the male rat”
  • “gender affirming hormone therapy in a rodent model of the transfemale rat.”
  • “Effects of gender affirming hormone therapy (GAHT) in mice”
  • “We developed a trans-masculine model by introducing either GnRHa or vehicle treatment to female-born mice at a pre-pubertal age.”
  • “investigate the reproductive effects of testosterone (T) therapy commonly used by transgender men”
  • “a transgender mouse model that allows for well-defined T cessation timing”
  • “Female mice were assigned to one of four experimental groups to mimic gender-affirming hormone therapy (GAHT) in human adolescents.”

The Gateway Pundit contacted all of the universities hosting the experiments for comment. Most did not respond, but Harvard denied that one of the grants was for transgender animal testing.

“It is completely inaccurate to describe this study as a ‘transgender animal’ study,” Harvard’s media relations team said in their response. “It is a basic science molecular biology study of how hormones (testosterone or estrogen) present in all of us change our body’s ability to heal wounds, which is clinically important. In the future, this research may support new approaches to heal the millions of Americans affected by chronic wounds at any time. A third of this study’s funding is focused on developing a better petri dish (non-mouse/non-animal) model to continue vital research.”

However, the grant clearly states that it is seeking to study healing in transgender people.

“A novel and promising way to better understand this link is to examine WH in transgender patients on exogenous hormones. However, research into the effects of gender-affirming hormones has not kept pace with rapid clinical population growth. We developed new models and showed that T limits wound healing in large animals with different effects in XX vs. XY animals. Further, we have shown that patients on T have impaired wound healing. A critical knowledge gap that remains unaddressed is the set of molecular mechanisms and pathways testosterone acts through to change the wound healing response.”

“This study seeks to transform current concepts of how hormones modulate wound repair with the dual aim of improving care for a marginalized patient population.”

Additionally, the Project Leader listed on the grant, Devin O’Brien Coon, is a surgeon who specializes in sex change surgeries.

According to his biography on the Brigham and Women’s Hospital website, Coon is “the system-wide Director of Gender Surgery for Mass General Brigham, leading one of the country’s largest academic gender-affirming surgery programs.”

“Dr. Coon’s clinical practice is focused on comprehensive gender-affirming surgery, cosmetic and facial plastic surgery,” the biography adds.

His most recent paper just so happens to be about mouse models of wound healing in transgender individuals after surgeries.

Like Harvard, Forbes was so hilariously eager to cover up the reality of these wasteful animal tests that they tripped over their fact-checking and gifted us a meta-masterpiece: an inaccuracy about an alleged inaccuracy.

The correction on the article now states:

Correction (Feb. 19, 2025): We removed a section on whether taxpayer funds were used to create “transgender mice” and monkeys after finding National Institutes of Health-backed studies—noted first by the anti-animal testing White Coat Waste Project—that did include surgery on mice and an additional grant for research on hormone therapy in monkeys, which were meant to replicate the effects of “gender-affirming care” methods used by transgender patients.

Maybe next time they will pause the sanctimony long enough to check receipts.

SHARE THIS POST